Literature DB >> 3260610

Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study.

J Hatazawa1, R A Brooks, M C Dalakas, L Mansi, G Di Chiro.   

Abstract

We previously reported generalized cerebral glucose hypometabolism in amyotrophic lateral sclerosis (ALS) patients with upper motor neuron disease, using positron emission tomography (PET) with [18F]2-fluoro-2-deoxy-D-glucose. The present article presents a more detailed regional analysis of the hypometabolism, including measurements of the motor-sensory cortex at higher levels than used earlier. The analysis is based on 19 PET studies of 12 patients with ALS, four of whom had only lower motor neuron involvement, and 11 studies of age-matched control subjects. A brain size correction was included to eliminate differences in metabolism related to brain size but not to pathology. The eight ALS patients with both upper and lower motor neuron disease showed generalized hypometabolism, compared with the normal control subjects, that was greatest in the motor-sensory cortex and putamen. The motor-sensory deficit was strongly correlated with length of disease, and a marked sequential reduction was seen in repeat studies on four of the patients. There was also significant right-left asymmetry in these scans. No cerebral hypometabolism was seen in the four ALS patients without upper motor neuron involvement. Although the observed motor-sensory deficit in ALS is consistent with histopathological findings, the more generalized hypometabolism and the asymmetry suggest more widespread effects.

Entities:  

Mesh:

Year:  1988        PMID: 3260610     DOI: 10.1097/00004728-198807000-00019

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  36 in total

Review 1.  Neuroimaging in amyotrophic lateral sclerosis.

Authors:  Sumei Wang; Elias R Melhem; Harish Poptani; John H Woo
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Widespread microstructural white matter involvement in amyotrophic lateral sclerosis: a whole-brain DTI study.

Authors:  M Cirillo; F Esposito; G Tedeschi; G Caiazzo; A Sagnelli; G Piccirillo; R Conforti; F Tortora; M R Monsurrò; S Cirillo; F Trojsi
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

3.  Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis.

Authors:  P J Massman; J Sims; N Cooke; L J Haverkamp; V Appel; S H Appel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

4.  Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice.

Authors:  Kazunori Miyazaki; Kazuto Masamoto; Nobutoshi Morimoto; Tomoko Kurata; Takahumi Mimoto; Takayuki Obata; Iwao Kanno; Koji Abe
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-09       Impact factor: 6.200

Review 5.  PET: its clinical role in neurology.

Authors:  D Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

Review 6.  Treatment of amyotrophic lateral sclerosis--what is the next step?

Authors:  A C Ludolph
Journal:  J Neurol       Date:  2000-12       Impact factor: 4.849

Review 7.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

Review 8.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

9.  Neuronal glucose metabolism is impaired while astrocytic TCA cycling is unaffected at symptomatic stages in the hSOD1G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Tesfaye W Tefera; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-19       Impact factor: 6.200

10.  Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients.

Authors:  K Nihei; A C McKee; N W Kowall
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.